Doctors can treat diabetes or metabolic syndrome by giving people that hormone as a drug, but the real root problem isnt a hormone deficiency
For patients with type 2 diabetes , semaglutide provides significant glycaemic benefits
Source: www.reuters.com (Reuters) In January 2026 , the Canadian pharmacy platform SaveRxCanada.to began offering India-sourced Ozempic pens to U.S
Efficacy and Safety of Oral Semaglutide in Patients With Type 2 Diabetes and Moderate Renal Impairment (PIONEER 5): A Placebo-Controlled, Randomised, Phase 3a Trial
GLP-1 activates the GLP-1 receptor (GLP-1R) in a glucose-dependent manner to potentiate insulin release and suppress glucagon secretion, and thereby lead to blood sugar lowering and weight loss [3][4]
Romero-Aristizabal, C., Marks, D